Recombinant IGF1R (Dalotuzumab Biosimilar) antibody
The Mammalian Cells Monoclonal anti-IGF1R (Dalotuzumab Biosimilar) antibody (ABIN7487949) specifically detects IGF1R (Dalotuzumab Biosimilar) in ELISA.
The antibody is reactive with Human samples.
Catalog No. ABIN7487949
$336.06
Plus shipping costs $50.00
Shipping to:
United States
Delivery in 7 to 10 Business Days
Quick Overview for Recombinant IGF1R (Dalotuzumab Biosimilar) antibody (ABIN7487949)
Target
IGF1R (Dalotuzumab Biosimilar)
Antibody Type
Recombinant Antibody
Reactivity
Human
Host
Mammalian Cells
Clonality
Monoclonal
Conjugate
This IGF1R (Dalotuzumab Biosimilar) antibody is un-conjugated
Application
ELISA
Grade
Research Grade
-
-
Expression System
- Mammalian cells
-
Purpose
- Dalotuzumab Biosimilar - Anti-IGF1R, CD221 mAb
-
Characteristics
- Antibody Type: IgG1-kappa
-
Purification
- Recombinant antibody expressed in mammalien cells and purified.
-
Isotype
- IgG1 kappa
-
-
-
-
Restrictions
- For Research Use only
-
-
-
Buffer
- PBS pH 7.5
-
Storage
- -80 °C
-
Storage Comment
- store at -80°C
-
-
- IGF1R (Dalotuzumab Biosimilar)
-
Target Type
- Biosimilar
-
Background
-
MK-0646
Dalotuzumab (MK-0646; h7C10), is a recombinant humanized IgG1 mAb against the IGF1R for the potential intravenous treatment of cancer, including Breast Cancer, Non-Small Cell Lung Cancer, and Metastatic Colorectal Cancer. -
CAS-No
- 1005389-60-5
Target
-
You are here:
